{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:34:08Z","timestamp":1793406848979,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007311","name":"Child Cancer Aid Trust of German Leukemia Research Support Initiative","doi-asserted-by":"publisher","award":["DKS 2020.17"],"award-info":[{"award-number":["DKS 2020.17"]}],"id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2022_EKMK.13"],"award-info":[{"award-number":["2022_EKMK.13"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["EKEA.174"],"award-info":[{"award-number":["EKEA.174"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ymthe.2025.01.009","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T19:39:45Z","timestamp":1736537985000},"page":"1031-1047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejection"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5228-7627","authenticated-orcid":false,"given":"Anna Christina","family":"Dragon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Bonifacius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Lienenklaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Verboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Phillipp","family":"Gerhards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hudecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanca","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Blasczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Eiz-Vesper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.01.009_bib1","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/ajt.15323","article-title":"Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection","volume":"19","author":"Chong","year":"2019","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ymthe.2025.01.009_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14320","article-title":"Incidence, risk factors, treatment, and consequences of antibody-mediated kidney transplant rejection: A systematic review","volume":"35","author":"Hart","year":"2021","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.ymthe.2025.01.009_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/tri.13436","article-title":"The therapeutic challenge of late antibody-mediated kidney allograft rejection","volume":"32","author":"B\u00f6hmig","year":"2019","journal-title":"Transpl. Int."},{"key":"10.1016\/j.ymthe.2025.01.009_bib4","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1172\/JCI90597","article-title":"Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies","volume":"127","author":"Valenzuela","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.01.009_bib5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/ajt.14013","article-title":"Prospective Analyses of Circulating B Cell Subsets in ABO-Compatible and ABO-Incompatible Kidney Transplant Recipients","volume":"17","author":"Schl\u00f6\u00dfer","year":"2017","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ymthe.2025.01.009_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4(+) CAR T\u00a0cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.01.009_bib7","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1111\/ajt.14912","article-title":"Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation","volume":"18","author":"Ius","year":"2018","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ymthe.2025.01.009_bib8","first-page":"1115","article-title":"Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure","volume":"21","author":"Altermann","year":"2006","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ymthe.2025.01.009_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jim.2016.01.007","article-title":"Assessment of costimulation and coinhibition in a triple parameter T\u00a0cell reporter line: Simultaneous measurement of NF-\u03baB, NFAT and AP-1","volume":"430","author":"Jutz","year":"2016","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ymthe.2025.01.009_bib10","doi-asserted-by":"crossref","first-page":"32786","DOI":"10.1074\/jbc.M102498200","article-title":"The human CD8 coreceptor effects cytotoxic T\u00a0cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T\u00a0cell receptor zeta chain","volume":"276","author":"Purbhoo","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.009_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.839783","article-title":"GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD(2) and Releasing Inducible IL-18","volume":"13","author":"Glienke","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.009_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2015.247","article-title":"Chimeric antigen receptor-modified T\u00a0cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in\u00a0vivo","volume":"30","author":"Sommermeyer","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2025.01.009_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ymthe.2020.09.011","article-title":"CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients","volume":"29","author":"Amini","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.01.009_bib14","article-title":"Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation","volume":"11","author":"Hsiao","year":"2021","journal-title":"J.\u00a0Pers. Med."},{"key":"10.1016\/j.ymthe.2025.01.009_bib15","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/eji.202049064","article-title":"CAR T\u00a0cells: Building on the CD19 paradigm","volume":"51","author":"Globerson Levin","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.009_bib16","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.ymthe.2017.06.008","article-title":"Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase","volume":"25","author":"Walker","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.01.009_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/42523","article-title":"Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2","volume":"387","author":"Gao","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.01.009_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/01.tp.0000259017.32857.99","article-title":"HLA-specific B cells: I. A method for their detection, quantification, and isolation using\u00a0HLA tetramers","volume":"83","author":"Zachary","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2025.01.009_bib19","article-title":"Depletion of alloreactive B cells by chimeric alloantigen receptor T\u00a0cells with drug resistance to prevent antibody-mediated rejection in solid organ transplantation","author":"Dragon","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2025.01.009_bib20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/tan.15146","article-title":"Chimeric HLA antibody receptor T\u00a0cells to target HLA-specific B cells in solid organ transplantation","volume":"102","author":"Gille","year":"2023","journal-title":"Hla"},{"key":"10.1016\/j.ymthe.2025.01.009_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/tan.15156","article-title":"Chimeric HLA antibody receptor T\u00a0cells for targeted therapy of antibody-mediated rejection in transplantation","volume":"102","author":"Betriu","year":"2023","journal-title":"Hla"},{"key":"10.1016\/j.ymthe.2025.01.009_bib22","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T\u00a0cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.01.009_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.01.009_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection","volume":"29","author":"Eskandary","year":"2018","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.01.009_bib25","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2016070727","article-title":"Humoral Compensation after Bortezomib Treatment of Allosensitized Recipients","volume":"28","author":"Kwun","year":"2017","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.01.009_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T\u00a0cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.01.009_bib27","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1172\/JCI138416","article-title":"Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris","volume":"130","author":"Lee","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.01.009_bib28","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/bloodadvances.2018018556","article-title":"Engineered FVIII-expressing cytotoxic T\u00a0cells target and kill FVIII-specific B cells in\u00a0vitro and in\u00a0vivo","volume":"2","author":"Parvathaneni","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.01.009_bib29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41587-022-01637-z","article-title":"Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T\u00a0cells","volume":"41","author":"Oh","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.01.009_bib30","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1016\/j.cell.2023.10.001","article-title":"Chimeric autoantibody receptor T\u00a0cells deplete NMDA receptor-specific B cells","volume":"186","author":"Reincke","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.01.009_bib31","article-title":"CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B\u221735 control Epstein-Barr virus-associated lymphoproliferation","volume":"8","author":"Dragon","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.01.009_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:07:02Z","timestamp":1778616422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1525001625000139"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.009","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejection","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}